P. Fularski, J. Hajdys, G. Majchrowicz, M. Stabrawa, E. Mlynarska et al., Unveiling Familial Hypercholesterolemia-Review, cardiovascular complications, Lipid-Lowering treatment and its efficacy. Int. J. Mol. Sci. 25(3) (2024). https://doi.org/10.3390/ijms25031637

von A. Eckardstein, B.G. Nordestgaard, A.T. Remaley, A.L. Catapano, High-density lipoprotein revisited: biological functions and clinical relevance. Eur. Heart J. 44(16), 1394–1407 (2023). https://doi.org/10.1093/eurheartj/ehac605

Article  Google Scholar 

A.C. Jansen, van E.S. Aalst-Cohen, M.W. Tanck, M.D. Trip, P.J. Lansberg et al., The contribution of classical risk factors to cardiovascular disease in Familial hypercholesterolaemia: data in 2400 patients. J. Intern. Med. 256(6), 482–490 (2004). https://doi.org/10.1111/j.1365-2796.2004.01405.x

Article  PubMed  CAS  Google Scholar 

J.T. Real, F.J. Chaves, I. Martinez-Uso, A.B. Garcia-Garcia, J.F. Ascaso et al., Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous Familial hypercholesterolaemia. Eur. Heart J. 22(6), 465–471 (2001). https://doi.org/10.1053/euhj.2000.2408

Article  PubMed  CAS  Google Scholar 

T.G. Richardson, E. Sanderson, T.M. Palmer, M. Ala-Korpela, B.A. Ference et al., Evaluating the relationship between Circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLoS Med. 17(3), e1003062 (2020). https://doi.org/10.1371/journal.pmed.1003062

Article  PubMed  PubMed Central  CAS  Google Scholar 

C.M. Madsen, A. Varbo, B.G. Nordestgaard, Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur. Heart J. 38(32), 2478–2486 (2017). https://doi.org/10.1093/eurheartj/ehx163

Article  PubMed  CAS  Google Scholar 

P. Barter, J. Genest, HDL cholesterol and ASCVD risk stratification, Debate Atherosclerosis. 283, 7–12 (2019). https://doi.org/10.1016/j.atherosclerosis.2019.01.001

Article  PubMed  CAS  Google Scholar 

C.V. Rizos, V. Athyros, E. Bilianou, G. Chrousos, A. Garoufi et al., An insight into Familial hypercholesterolemia in greece: rationale and design of the Hellenic Familial hypercholesterolemia registry (HELLAS-FH). Horm. (Athens). 16(3), 306–312 (2017). https://doi.org/10.1007/BF03401525

Article  Google Scholar 

C.V. Rizos, I. Skoumas, L. Rallidis, E. Skalidis, K. Tziomalos et al., LDL cholesterol target achievement in heterozygous Familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: implications for newer lipid-lowering treatments. Int. J. Cardiol. 345, 119–124 (2021). https://doi.org/10.1016/j.ijcard.2021.10.024

Article  PubMed  Google Scholar 

C.V. Rizos, M. Florentin, I. Skoumas, K. Tziomalos, L. Rallidis et al., Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with Familial hypercholesterolemia: an analysis from the HELLAS-FH registry. Lipids Health Dis. 19(1), 114 (2020). https://doi.org/10.1186/s12944-020-01289-5

Article  PubMed  PubMed Central  CAS  Google Scholar 

B.G. Nordestgaard, M.J. Chapman, S.E. Humphries, H.N. Ginsberg, L. Masana et al., Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European atherosclerosis society. Eur. Heart J. 34(45), 3478–3490a (2013). https://doi.org/10.1093/eurheartj/eht273

Article  PubMed  PubMed Central  CAS  Google Scholar 

F. Civeira, E. Ros, E. Jarauta, N. Plana, D. Zambon et al., Comparison of genetic versus clinical diagnosis in Familial hypercholesterolemia. Am. J. Cardiol. 102(9), 1187–1193 (2008). https://doi.org/10.1016/j.amjcard.2008.06.056

Article  PubMed  CAS  Google Scholar 

W.J. Youden, Index for rating diagnostic tests cancer 3(1), 32–35 (1950). https://doi.org/10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3

M.J. Veerkamp, de J. Graaf, S.J. Bredie, J.C. Hendriks, P.N. Demacker et al., Diagnosis of Familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler. Thromb. Vasc Biol. 22(2), 274–282 (2002). https://doi.org/10.1161/hq0202.104059

Article  PubMed  CAS  Google Scholar 

P.W. Connelly, A. Petrasovits, S. Stachenko, D.R. MacLean, J.A. Little et al., Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Can. Heart Health Surv. Res. Group. Can. J. Cardiol. 15(4), 428–433 (1999)

CAS  Google Scholar 

A.M. Kaneva, N.N. Potolitsyna, E.R. Bojko, Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile. Arch. Physiol. Biochem. 123(1), 16–22 (2017). https://doi.org/10.1080/13813455.2016.1195411

Article  PubMed  CAS  Google Scholar 

J. Vekic, A. Zeljkovic, A.F.G. Cicero, A. Janez, A.P. Stoian et al., Atherosclerosis development and progression: the role of atherogenic small. Dense LDL Med. (Kaunas). 58(2) (2022). https://doi.org/10.3390/medicina58020299

E. Taylan, E.P. Tuncel, Distribution of LDL subgroups in patients with hyperlipidemia Turk. J. Med. Sci. 46(2), 374–380 (2016). https://doi.org/10.3906/sag-1410-40

Article  CAS  Google Scholar 

F. Zhang, Y. Zhang, J. Zhang, X. Wang, Y. Li et al., Small dense low density lipoprotein predominance in patients with type 2 diabetes mellitus using Mendelian randomization. PLoS One. 19(2), e0298070 (2024). https://doi.org/10.1371/journal.pone.0298070

Article  PubMed  PubMed Central  CAS  Google Scholar 

Emerging Risk Factors Collaboration, Di E. Angelantonio, N. Sarwar, P. Perry, S. Kaptoge et al., Major lipids, apolipoproteins, and risk of vascular disease JAMA 302(18), 1993–2000 (2009). https://doi.org/10.1001/jama.2009.1619

Article  Google Scholar 

B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic et al., Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study lancet 380(9841), 572–580 (2012). https://doi.org/10.1016/S0140-6736(12)60312-2

M.V. Holmes, F.W. Asselbergs, T.M. Palmer, F. Drenos, M.B. Lanktree et al., Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36(9), 539–550 (2015). https://doi.org/10.1093/eurheartj/eht571

Article  PubMed  CAS  Google Scholar 

L. Perez de Isla, G.F. Watts, O. Muniz-Grijalvo, J.L. Diaz-Diaz, R. Alonso et al., A resilient type of Familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort. Eur. J. Prev. Cardiol. 29(5), 795–801 (2022). https://doi.org/10.1093/eurjpc/zwab185

Article  PubMed  Google Scholar 

L.E. Akioyamen, J. Genest, A. Chu, H. Inibhunu, D.T. Ko et al., Risk factors for cardiovascular disease in heterozygous Familial hypercholesterolemia: A systematic review and meta-analysis. J. Clin. Lipidol. 13(1), 15–30 (2019). https://doi.org/10.1016/j.jacl.2018.10.012

Article  PubMed  Google Scholar 

M. Paquette, R. Dufour, A. Baass, The Montreal-FH-SCORE: A new score to predict cardiovascular events in Familial hypercholesterolemia. J. Clin. Lipidol. 11(1), 80–86 (2017). https://doi.org/10.1016/j.jacl.2016.10.004

Article  PubMed  Google Scholar 

L. Perez de Isla, R. Alonso, N. Mata, C. Fernandez-Perez, O. Muniz et al., Predicting cardiovascular events in Familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial hypercholesterolemia cohort study. Circulation. 135(22), 2133–2144 (2017). https://doi.org/10.1161/CIRCULATIONAHA.116.024541

Article  PubMed  Google Scholar 

M. Paquette, S. Bernard, B. Cariou, R.A. Hegele, J. Genest et al., Familial hypercholesterolemia-Risk-Score: A new score predicting cardiovascular events and cardiovascular mortality in Familial hypercholesterolemia. Arterioscler. Thromb. Vasc Biol. 41(10), 2632–2640 (2021). https://doi.org/10.1161/ATVBAHA.121.316106

Article  PubMed  CAS  Google Scholar 

P. Anagnostis, C.V. Rizos, G. Liamis, L. Rallidis, I. Skoumas et al., Exploring the correlation between triglyceride levels and atherosclerotic cardiovascular disease prevalence in adults with Familial hypercholesterolemia: insights from a cross-sectional analysis in the HELLAS-FH registry J clin lipidol Epub ahead of print (2025). https://doi.org/10.1016/j.jacl.2024.12.017

S. Ragbir, J.A. Farmer, Dysfunctional high-density lipoprotein and atherosclerosis. Curr. Atheroscler Rep. 12(5), 343–348 (2010). https://doi.org/10.1007/s11883-010-0091-x

Article  PubMed  CAS  Google Scholar 

K.G. Lagos, T.D. Filippatos, V. Tsimihodimos, I.F. Gazi, C. Rizos et al., Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome lipids 44(1), 9–16 (2009). https://doi.org/10.1007/s11745-008-3251-9

J. Pedro-Botet, E. Climent, D. Benaiges, Familial hypercholesterolemia: do HDL play a role?? Biomedicines 9(7)(2021). https://doi.org/10.3390/biomedicines9070810

S. Ganjali, S. Hosseini, M. Rizzo, A. Kontush, A. Sahebkar, Capacity of HDL to efflux cellular cholesterol from Lipid-Loaded macrophages is reduced in patients with. Familial Hypercholesterolemia Metabolites. 13(2) (2023). https://doi.org/10.3390/metabo13020197

J. Versmissen, R. Vongpromek, R. Yahya, van der J.B. Net, van L. Vark-van et al., Familial hypercholesterolaemia: cholesterol efflux and coronary disease. Eur. J. Clin. Invest. 46(7), 643–650 (2016). https://doi.org/10.1111/eci.12643

Article  PubMed  PubMed Central  CAS  Google Scholar 

J.C. Escola-Gil, N. Rotllan, J. Julve, F. Blanco-Vaca, Reverse cholesterol transport dysfunction is a feature of Familial hypercholesterolemia. Curr. Atheroscler Rep. 23(6), 29 (2021). https://doi.org/10.1007/s11883-021-00928-1

Article